Click any highlighted term for further explanation. For more information, contact technical support.
|
|
Details
|
|
Vulnerability name/brief description
|
APSB12-08 - Security update for Adobe Reader and Acrobat
|
|
CVE/CAN name
|
|
|
Vendor threat level
|
Critical
|
|
SophosLabs threat level
|
Critical
|
|
Solution
|
APSB12-08
|
|
Vendor description
|
These updates address critical vulnerabilities in Adobe Reader X (10.1.2) and earlier versions for Windows, Macintosh, Adobe Reader 9.4.6 and earlier 9.x versions for Linux and Adobe Acrobat X (10.1.2) and earlier versions for Windows and Macintosh. These updates address vulnerabilities in the software that could cause the application to crash and potentially allow an attacker to take control of the affected system.
Adobe recommends users of Adobe Reader X (10.1.2) and earlier versions for Windows and Macintosh update to Adobe Reader X (10.1.3). For users of Adobe Reader 9.5 and earlier versions for Windows and Macintosh, who cannot update to Adobe Reader X (10.1.3), Adobe has made available the update Adobe Reader 9.5.1. Adobe recommends users of Adobe Acrobat 9.5 and earlier versions for Windows and Macintosh update to Adobe Acrobat 9.5.1.
|
|
SophosLabs comments
|
Adobe Acrobat exploits account for a significant proportion of all vulnerabilities that SophosLabs see. We expect that the items mentioned will likely be exploited in the near future.
|
|
SophosLabs testing result
|
No SophosLabs testing result found
|
|
Currently known exploits
|
No currently known exploits found
|
|
First sample seen
|
No samples found
|
|
Discovery date
|
05 Apr 2012
|
|
Affected software
|
Adobe Reader X (10.1.2) and earlier 10.x versions for Windows and Macintosh
Adobe Reader 9.5 and earlier 9.x versions for Windows and Macintosh
Adobe Reader 9.4.6 and earlier 9.x versions for Linux
Adobe Acrobat X (10.1.2) and earlier 10.x versions for Windows and Macintosh
Adobe Acrobat 9.5 and earlier 9.x versions for Windows and Macintosh
|
|
References
|
|
|
Credits
|
-
Peter Vreugdenhil through TippingPoints Zero Day Initiative (CVE-2012-0774)
-
Soroush Dalili (CVE-2012-0775)
-
Mitja Kolsek of ACROS Security (CVE-2012-0776)
-
Jamers Quirk, Los Alamos (CVE-2012-0777)
|
|
Revisions
|
-
April 5, 2012 - Initial analysis written
|
Explanation of terms
Vulnerability Name/Brief Description:
Vendor identifier plus a brief description of the type of attack.
CVE/CAN Name:
Currently assigned CVE name. If a CVE name doesn't exist the CAN name will be used until a CVE has been assigned.
Vendor Threat Level:
Threat level assigned by the vendor
SophosLabs Threat Level:
Threat level assigned by SophosLabs
- LOW RISK - There is little chance of this vulnerability being actively exploited by malware.
- MEDIUM RISK - There is a possibility of this vulnerability being actively exploited by malware.
- HIGH RISK - There is a strong possibility of this vulnerability being actively exploited by malware.
- CRITICAL RISK - This vulnerability will almost certainly be actively exploited by malware.
Solution:
Vendor-supplied Patch identifier and recommended solution, or workaround if applicable.
Vendor Description:
Summary of the cause and potential effect of the vulnerability provided by the vendor.
SophosLabs Comments:
SophosLabs' opinions and observations of the vulnerability in question.
SophosLabs Testing Result:
Details of completed lab testing, if applicable. Please note that the lab test environment may differ significantly from user environments.
Currently Known Exploits:
List of identities for known exploits, if applicable.
First Sample Seen:
Date of the first sample seen by SophosLabs.
Discovery Date:
Date of the earliest known publically disclosed advisory.
Affected Software:
Vulnerable platforms and software versions.